More specifically, HER2 downregulation is associated with inhibition of proliferation and invasion of HER2-positive human breast cancer cells [58]; this correlates with our results of EA-induced decreased cell proliferation, cell invasion, and colony formation. The gene discussed is ERBB2; the disease is breast cancer.